609 related articles for article (PubMed ID: 9464621)
1. Favourable melanoma prognosis associated with the expression of the tumour necrosis factor receptor and the alpha1beta1 integrin: a preliminary report.
Gilhar A; Ullmann Y; Kalish RS; Berkutski T; Azizi E; Bank I
Melanoma Res; 1997 Dec; 7(6):486-95. PubMed ID: 9464621
[TBL] [Abstract][Full Text] [Related]
2. Two human melanoma cell-line variants with enhanced in vivo tumor growth and metastatic capacity do not express the beta 3 integrin subunit.
Boukerche H; Benchaibi M; Berthier-Vergnes O; Lizard G; Bailly M; Bailly M; McGregor JL
Eur J Biochem; 1994 Mar; 220(2):485-91. PubMed ID: 8125107
[TBL] [Abstract][Full Text] [Related]
3. Metastatic potential of human melanoma cells in nude mice--characterisation of phenotype, cytokine secretion and tumour-associated antigens.
Schadendorf D; Fichtner I; Makki A; Alijagic S; Küpper M; Mrowietz U; Henz BM
Br J Cancer; 1996 Jul; 74(2):194-9. PubMed ID: 8688321
[TBL] [Abstract][Full Text] [Related]
4. Increased gene expression levels of collagen receptor integrins are associated with decreased survival parameters in patients with advanced melanoma.
Vuoristo M; Vihinen P; Vlaykova T; Nylund C; Heino J; Pyrhönen S
Melanoma Res; 2007 Aug; 17(4):215-23. PubMed ID: 17625451
[TBL] [Abstract][Full Text] [Related]
5. Cytokine-mediated modulation of integrin, ICAM-1 and CD44 expression on human uveal melanoma cells in vitro.
Creyghton WM; de Waard-Siebinga I; Danen EH; Luyten GP; van Muijen GN; Jager MJ
Melanoma Res; 1995 Aug; 5(4):235-42. PubMed ID: 7496158
[TBL] [Abstract][Full Text] [Related]
6. Thioredoxin, thioredoxin reductase and tumour necrosis factor-alpha expression in melanoma cells: correlation to resistance against cytotoxic attack.
Barral AM; Källström R; Sander B; Rosén A
Melanoma Res; 2000 Aug; 10(4):331-43. PubMed ID: 10985667
[TBL] [Abstract][Full Text] [Related]
7. Role of Integrins α1β1 and α2β1 in Wound and Tumor Angiogenesis in Mice.
Ghatak S; Niland S; Schulz JN; Wang F; Eble JA; Leitges M; Mauch C; Krieg T; Zigrino P; Eckes B
Am J Pathol; 2016 Nov; 186(11):3011-3027. PubMed ID: 27639165
[TBL] [Abstract][Full Text] [Related]
8. Alpha v-integrins in human melanoma: gain of alpha v beta 3 and loss of alpha v beta 5 are related to tumor progression in situ but not to metastatic capacity of cell lines in nude mice.
Danen EH; Jansen KF; Van Kraats AA; Cornelissen IM; Ruiter DJ; Van Muijen GN
Int J Cancer; 1995 May; 61(4):491-6. PubMed ID: 7538977
[TBL] [Abstract][Full Text] [Related]
9. A model of human cancer metastasis: extensive spontaneous and artificial metastasis of a human pigmented melanoma and derived variant sublines in nude mice.
Kerbel RS; Man MS; Dexter D
J Natl Cancer Inst; 1984 Jan; 72(1):93-108. PubMed ID: 6582307
[TBL] [Abstract][Full Text] [Related]
10. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
11. In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.
Mitjans F; Meyer T; Fittschen C; Goodman S; Jonczyk A; Marshall JF; Reyes G; Piulats J
Int J Cancer; 2000 Sep; 87(5):716-23. PubMed ID: 10925366
[TBL] [Abstract][Full Text] [Related]
12. Vla and alpha 6 beta 4 integrin expression in neuroendocrine carcinomas of the skin (their xenografts on nude mice and a corresponding primary culture).
Perrin C; Pisani A; Demarchez M; Michiel JF; Ortonne JP
J Cutan Pathol; 1996 Jun; 23(3):223-8. PubMed ID: 8793656
[TBL] [Abstract][Full Text] [Related]
13. Exposure of melanoma cells to dacarbazine results in enhanced tumor growth and metastasis in vivo.
Lev DC; Onn A; Melinkova VO; Miller C; Stone V; Ruiz M; McGary EC; Ananthaswamy HN; Price JE; Bar-Eli M
J Clin Oncol; 2004 Jun; 22(11):2092-100. PubMed ID: 15123733
[TBL] [Abstract][Full Text] [Related]
14. Integrin expression by primary and immortalized human chondrocytes: evidence of a differential role for alpha1beta1 and alpha2beta1 integrins in mediating chondrocyte adhesion to types II and VI collagen.
Loeser RF; Sadiev S; Tan L; Goldring MB
Osteoarthritis Cartilage; 2000 Mar; 8(2):96-105. PubMed ID: 10772239
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Maio M; Gulwani B; Morgano A; Ferrone S
Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
[TBL] [Abstract][Full Text] [Related]
17. A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins.
Elshaw SR; Sisley K; Cross N; Murray AK; MacNeil SM; Wagner M; Nichols CE; Rennie IG
Br J Ophthalmol; 2001 Jun; 85(6):732-8. PubMed ID: 11371496
[TBL] [Abstract][Full Text] [Related]
18. Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells.
Danen EH; van Muijen GN; van de Wiel-van Kemenade E; Jansen KF; Ruiter DJ; Figdor CG
Int J Cancer; 1993 May; 54(2):315-21. PubMed ID: 8387465
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice.
van Muijen GN; Jansen KF; Cornelissen IM; Smeets DF; Beck JL; Ruiter DJ
Int J Cancer; 1991 Apr; 48(1):85-91. PubMed ID: 2019461
[TBL] [Abstract][Full Text] [Related]
20. alpha6beta1 integrin expression in hepatocarcinoma cells: regulation and role in cell adhesion and migration.
Nejjari M; Hafdi Z; Dumortier J; Bringuier AF; Feldmann G; Scoazec JY
Int J Cancer; 1999 Nov; 83(4):518-25. PubMed ID: 10508489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
